Medica launches a new cardiac drug on the market!
In early March Medica launched its new cardiac drug Telmimed Plus.
Telmimed Plus is a combination of two active substances in one tablet – telmisartan and hydrochlorothiazide, and is used to treat high blood pressure. The product is subject to medical prescription, and the market offers two forms Telmimed Plus 80 mg/25 mg and Telmimed Plus 80 mg/12, 5 mg.
Telmimed Plus is a combination of two active substances in one tablet – telmisartan and hydrochlorothiazide, and is used to treat high blood pressure. The product is subject to medical prescription, and the market offers two forms Telmimed Plus 80 mg/25 mg and Telmimed Plus 80 mg/12, 5 mg.